Drugs & Aging

, Volume 11, Issue 5, pp 374–397 | Cite as

Immunodeficiency of Aging

Review Article Physiological Aspects of Aging

Summary

Aging is associated with declines in multiple areas of immune function, but to date no single mechanism has emerged as being responsible for all the observed changes. Many changes occur at different rates within individuals as well as between individuals. With advancing age there is a concomitant increase in the incidence of many infections and cancers. It is being increasingly acknowledged that autoimmune processes play a proinflammatory role in the development of many pathological conditions, such as atherosclerosis. However, direct causal relationships between specific changes in immunity and the occurrence of specific diseases are rare. There is accumulating epidemiological, in vivo and in vitro evidence to support many such direct relationships in both animals and humans. It is likely that the mechanisms underlying age-related changes in immunity are multifactorial, with both genetic and environmental factors playing a significantrole. Despite the current lack of unifying theories, much active and exciting work is proceeding in the area of immune stimulation. Studies describing age-related changes in immunity, as well as the testing of interventions to reverse these changes, will continue to fill the gaps in our knowledge, leading to a more comprehensive understanding of immunosenescence.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Roberts-Thompson IC, Whittingham S, Young-Chaiyud U, et al. Aging, immune response and mortality. Lancet 1974; II: 368–70Google Scholar
  2. 2.
    Goodwin JS, Searles RP, Tung KSK. Immunological responses of a healthy elderly population. Clin Exp Immunol 1982; 48: 403–10PubMedGoogle Scholar
  3. 3.
    Hess EV, Knapp D. The immune system and aging: a case of the cart before the horse. J Chronic Dis 1978; 31: 647–9PubMedGoogle Scholar
  4. 4.
    Miller RA. Aging and immune function. Int Rev Cytol 1991; 124: 187–215PubMedGoogle Scholar
  5. 5.
    Philosophe B, Miller RA. Diminished calcium signal generation in subsets of T lymphocytes that predominate in old mice. J Gerontol 1990; 45: B87–93PubMedGoogle Scholar
  6. 6.
    Nijhuis EW, Remarque EJ, Hinloopen B, et al. Age-related increase in the fraction of CD27-CD4+ T cells and IL-4 production as a feature of CD4+ T cell differentiation in vivo. Clin Exp Immunol 1994; 96: 528–34PubMedGoogle Scholar
  7. 7.
    Jackola DR, Ruger JK, Miller RA. Age-associated changes in human T cell phenotype and function. Aging 1994; 6: 25–34PubMedGoogle Scholar
  8. 8.
    Xu X, Beckman I, Ahern M, et al. A comprehensive analysis of peripheral blood lymphocytes in healthy aged humans by flow cytometry. Immunol Cell Biol 1993; 71: 549–57PubMedGoogle Scholar
  9. 9.
    Kudlacek S, Jahandideh-Kazempour S, Graninger W, et al. Differential expression of various T cell surface markers in young and elderly subjects. Immunobiology 1995; 192: 198–204PubMedGoogle Scholar
  10. 10.
    Jackola DR, Ruger JK, Miller RA. Age-associated changes in human T cell phenotype and function. Aging 1994; 6: 25–34PubMedGoogle Scholar
  11. 11.
    Dobber R, Tielemans M, Nagelkerken L. Enrichment for Thl cells in the Mel-14+ CD4+ T cell fraction in aged mice. Cell Immunol 1995; 162: 321–5PubMedGoogle Scholar
  12. 12.
    Dobber R, Tielemans M, de Weerd H, et al. Mel14-hCD4+ T cells from aged mice display functional and phenotypic characteristics of memory cells. Int Immunol 1994; 6: 1227–34PubMedGoogle Scholar
  13. 13.
    Murasko DM, Weiner P, Kaye D. Association of lack of mitogen-induced lymphocyte proliferation with increased mortality in the elderly. Aging Immunol Infect Dis 1988; 1: 1–6Google Scholar
  14. 14.
    Inkeles B, Innes JB, Kuntz MM, et al. Immunological studies of aging: III. Cytokinetic basis for the impaired response of lymphocytes from aged humans to plant lectins. J Exp Med 1977; 145: 1176–87PubMedGoogle Scholar
  15. 15.
    Goodwin JS, Messner RP. Sensitivity of lymphocytes to prostaglandin E2 increases in subjects over age 70. J Clin Invest 1979; 64: 434–9PubMedGoogle Scholar
  16. 16.
    Kirschmann DA, Murasko DM. Splenic and inguinal lymph node T cells of aged mice respond differently to polyclonal and antigen-specific stimuli. Cell Immunol 1992; 139: 426–37PubMedGoogle Scholar
  17. 17.
    Ernst DN, Weigle WO, McQuitty DN, et al. Stimulation of murine T cell subsets with anti-CD3 antibody: age-related defects in the expression of early activation molecules. J Immunol 1989; 142: 1413–21PubMedGoogle Scholar
  18. 18.
    Vissinga C, Nagelkerken L, Sijlstra J, et al. A decreased functional capacity of CD4+ T cells underlies the impaired DTH reactivity in old mice. Mech Ageing Dev 1990; 53: 127–39PubMedGoogle Scholar
  19. 19.
    Gottesman SRS, Edington J. Proliferative and cytotoxic immune functions in aging mice: V. Deficiency in generation of cytotoxic cells with normal lytic function per cell as demonstrated by the single cell conjugation assay. Aging Immunol Infect Dis 1990; 2: 19–29Google Scholar
  20. 20.
    Kishimoto S, Tomino S, Mitsuya H, et al. Age-related changes in suppressor functions of human T cells. J Immunol 1979; 123: 1586–92PubMedGoogle Scholar
  21. 21.
    Crawford J, Oates S, Wolfe LA, et al. An in vitro analogue of immune dysfunction with altered immunoglobulin production in the aged. J Am Geriatr Soc 1989; 37: 1141–6Google Scholar
  22. 22.
    Grossmann A, Ledbetter JA, Rabinovitch PS. Reduced proliferation in T lymphocytes in aged humans is predominantly in the CD8+ subset and is unrelated to defects in transmembrane signaling which are predominantly in the CD4+ subsets. Exp Cell Res 1989; 180: 367–82PubMedGoogle Scholar
  23. 23.
    Doria G, Mancini C, Frasca D, et al. Age restriction in antigen-specific immunosuppression. J Immunol 1987; 139: 1419–25PubMedGoogle Scholar
  24. 24.
    Russo C, Cherniak EP, Wali A, et al. Age-dependent appearance of non-major histocompatibility complex-restricted helper T cells. Proc Natl Acad Sci U S A 1993; 90: 11718–22PubMedGoogle Scholar
  25. 25.
    Hara H, Negoro S, Miyata S, et al. Age-associated changes in proliferative and differentiative response of human B cells and production of T cell-derived factors regulating B cell functions. Mech Ageing Dev 1987; 38: 245–58PubMedGoogle Scholar
  26. 26.
    Schwab R, Russo C, Weksler ME. Altered major histocompatibility complex-restricted antigen recognition by T cells from elderly humans. Eur J Immunol 1992; 22: 2989–93PubMedGoogle Scholar
  27. 27.
    Zhao KS, Wang YF, Gueret R, et al. Dysregulation of the humoral immune response in old mice. Int Immunol 1995; 7: 929–34PubMedGoogle Scholar
  28. 28.
    Hallgren H, Buckley C, Gilbertson V, et al. Lymphocyte phytohemagglutinin responsiveness, immunoglobulins, and autoantibodies in aging humans. J Immunol 1973; 111: 1101–7PubMedGoogle Scholar
  29. 29.
    Lewis RS, Cahalan MD. Potassium and calcium channels in lymphocytes. Ann Rev Immunol 1995; 13: 623–53Google Scholar
  30. 30.
    Jayaraman T, Ondriasova E, Ondrias K, et al. The inositol 1,4,5-trisphosphate receptor is essential for T-cell receptor signaling. Proc Natl Acad Sci U S A 1995; 92: 6007–11PubMedGoogle Scholar
  31. 31.
    Zweifach A, Lewis RS. Mitogen-regulated Ca2+ current of T lymphocytes is activated by depletion of intracellular Ca2+ stores. Proc Natl Acad Sci U S A 1993; 90: 6295–9PubMedGoogle Scholar
  32. 32.
    Miller RA, Philosophe B, Ginis I, et al. Defective control of cytoplasmic calcium concentration in T lymphocytes from old mice. J Cell Physiol 1989; 128: 175–82Google Scholar
  33. 33.
    Miller RA. Calcium signals in T lymphocytes from old mice. Life Sci 1996; 59: 469–75PubMedGoogle Scholar
  34. 34.
    Fultop Jr T, Barabas G, Varga Z, et al. Transmembrane signaling changes with aging. Ann N Y Acad Sci 1992; 673: 165–71Google Scholar
  35. 35.
    Philosophe B, Miller RA. Calcium signals in murine T lymphocytes: preservation of response to PHA and to an anti-Ly-6 antibody. Aging Immunol Infect Dis 1990; 2: 11–8Google Scholar
  36. 36.
    Kawanishi H, Ajitsu S, Mirabella S. Impaired humoral immune responses to mycobacterial andgen in aged murine gut-associated lymphoid tissues. Mech Ageing Dev 1990; 54: 143–61PubMedGoogle Scholar
  37. 37.
    Lustyik G, O’Leary JJ. Aging and the mobilization of intracellular calcium by phytohemagglutinin in human T cells. J Gerontol 1989; 44: B30–6PubMedGoogle Scholar
  38. 38.
    Jackola DR, Hallgren HM. Diminished cell-cell binding by lymphocytes from healthy elderly humans: evidence for altered activation of LEA-1 function with age. J Gerontol 1995; 50: B368–77Google Scholar
  39. 39.
    Whisler RL, Newhouse YG, Bagenstose SE. Age-related reductions in the activation of mitogen-activated protein kinases p44mapk/ERK1 and p42mapk/ERK2 in human T cells sdmulated via ligation of the T cell receptor complex. Cell Immunol 1996; 168: 201–10PubMedGoogle Scholar
  40. 40.
    Whisler RL, Newhouse YG, Grants IS, et al. Differendal expression of the alpha- and beta-isoforms of protein kinase C in peripheral blood T and B cells from young and elderly adults. Mech Ageing Dev 1995; 77: 197–211PubMedGoogle Scholar
  41. 41.
    Patel HR, Miller RA. Age-associated changes in mitogen-induced protein phosphorylation in murine T lymphocytes. Eur J Immunol 1992; 22: 253–60PubMedGoogle Scholar
  42. 42.
    Shi J, Miller RA. Differendal tyrosine-specific protein phosphorylation in mouse T lymphocyte subsets: effect of age. J Immunol 1993; 151: 730–9PubMedGoogle Scholar
  43. 43.
    Whisler RL, Beiqing L, Chen M. Age-related decreases in IL-2 production by human T cells are associated with impaired activation of nuclear transcriptional factors AP-1 and NF-AT. Cell Immunol 1996; 169: 185–95PubMedGoogle Scholar
  44. 44.
    Whisler RL, Liu B, Wu LC, et al. Reduced activation of transcriptional factor AP-1 among peripheral blood T cells from elderly humans after PHA stimulation: restorative effect of phorbol diesters. Cell Immunol 1993; 152: 96–109PubMedGoogle Scholar
  45. 45.
    Makinodan T. Biology of aging: retrospect and prospect. In: Makinodan T, Yunis E, editors. Immunology and aging. New York: Plenum Press, 1977: 1–8Google Scholar
  46. 46.
    Callard R, Basten A, Blanden R. Loss of immune competence with age may be due to a qualitative abnormality in lymphocyte membranes. Nature 1979; 281: 218–21PubMedGoogle Scholar
  47. 47.
    Zharhary D. Age-related changes in the capability of the bone marrow to generate B cells. J Immunol 1988; 141: 1863–9PubMedGoogle Scholar
  48. 48.
    Ben-Yehuda A, Szabo P, Dyall R, et al. Bone marrow declines as a site of B-cell precursor differentiation with age: relation-ship to thymus involution. Proc Natl Acad Sci U S A 1994; 91: 11988–92PubMedGoogle Scholar
  49. 49.
    Viale AC, Chies JA, Huetz F, et al. VH-gene family dominance in ageing mice. Scand J Immunol 1994; 39: 184–8PubMedGoogle Scholar
  50. 50.
    Whisler RL, Grants IS. Age-related alterations in the activation and expression of phosphotyrosine kinases and protein kinase C (PKC) among human B cells. Mech Ageing Dev 1993; 71: 31–46PubMedGoogle Scholar
  51. 51.
    Delafuente JC. Immunosenescence: clinical and pharmacologic considerations. Med Clin North Am 1985; 69: 475–86PubMedGoogle Scholar
  52. 52.
    Arreaza EE, Gibbons Jr JJ, Siskind GW, et al. Lower andbody response to tetanus toxoid associated with higher auto-anti-idiotypic andbody in old compared with young humans. Clin Exp Immunol 1993; 92: 169–73PubMedGoogle Scholar
  53. 53.
    Cinader B, Thorbecke GJ. Aging and the immune system: report on workshop #94 held during the 7th International Congress of Immunology; 1989 Aug 3: Berlin. Aging Immunol Infect Dis 1990; 2: 45–53Google Scholar
  54. 54.
    Whittingham S, Buckley JD, Mackay IR. Factors influencing the secondary antibody response to flagellin in man. Clin Exp Immunol 1978; 34: 170–8PubMedGoogle Scholar
  55. 55.
    De Greef GE, Van Staalduinen GJ, Van Doorninck H, et al. Age-related changes of the antigen-specific antibody formation in vitro and PHA-induced T cell proliferation in individuals who met the Senieur protocol. Mech Ageing Dev 1992; 66: 1–14PubMedGoogle Scholar
  56. 56.
    Ligthart GJ, Corberand JX, Fournier C, et al. Admission criteria for immunogerontological studies in man: the Senieur protocol. Mech Ageing Dev 1984; 28: 47–55PubMedGoogle Scholar
  57. 57.
    Kishimoto S, Tomino S, Mitsuya H, et al. Age-related decrease in frequencies of B-cell precursors and specific helper T cells involved in the IgG anti-tetanus toxoid antibody production in humans. Clin Immunol Immunopathol 1982; 25: 1–10PubMedGoogle Scholar
  58. 58.
    Burns EA, Lum LG, Giddings BR, et al. Decreased specific antibody synthesis by lymphocytes from elderly subjects. Mech Ageing Dev 1990; 53: 229–41PubMedGoogle Scholar
  59. 59.
    Bums EA, Lum LG, I’Hommedieu GD, et al. Decreased humoral immunity in aging: in vivo and in vitro response to vaccination. J Gerontol 1993; 48: B231–6Google Scholar
  60. 60.
    Ennist DL, Hones KH, St Pierre RL, et al. Functional analysis of the immunosenescence of the human B cell system: dissociation of normal activation and proliferation from impaired terminal differentiation into IgM immunoglobulin-secreting cells. J Immunol 1986; 136: 99–105PubMedGoogle Scholar
  61. 61.
    Whisler RL, Williams JW, Newhouse YG. Human B cell proliferative responses during aging: reduced RNA synthesis and DNA replication after signal transduction by surface immunoglobulins compared to B cell antigenic determinants CD20 and CD40. Mech Ageing Dev 1991; 61: 209–222PubMedGoogle Scholar
  62. 62.
    Hu A, Ehleiter D, Ben-Yehuda A, et al. Effect of age on the expressed B cell repertoire: role of B cell subsets. Int Immunol 1993; 5: 1035–9PubMedGoogle Scholar
  63. 63.
    Nicoletti C, Yang X, Cerny J. Repertoire diversity of antibody response to bacterial antigens in aged mice: III. Phosphorylcholine antibody from young and aged mice differ in structure and protective activity against infection with Streptococcus pneumoniae. J Immunol 1993; 150: 543–9PubMedGoogle Scholar
  64. 64.
    Miller C, Kelsoe G. Ig VH hypermutation is absent in the germinal centers of aged mice. J Immunol 1995; 155: 3377–84PubMedGoogle Scholar
  65. 65.
    Delfraissey J, Galanaud P, Wallon C, et al. Abolished in vitro antibody response in the elderly: exclusive involvement of prostaglandin-induced T suppressor cells. Clin Immunol Immunopathol 1982; 24: 377–85Google Scholar
  66. 66.
    Delfraissey JF, Galanaud P, Dormont J, et al. Age-related impairment of the in vitro antibody response in the human. Clin Exp Immunol 1980; 39: 208–14Google Scholar
  67. 67.
    McLachlan JA, Serkin CD, Morrey-Clark KM, et al. Immunological functions of aged monocytes. Pathobiology 1995; 63: 148–59PubMedGoogle Scholar
  68. 68.
    Danon D, Kowatch MA, Roth GS. Promotion of wound repair in old mice by local injection of macrophages. Proc Natl Acad Sci U S A 1989; 86: 2018–20PubMedGoogle Scholar
  69. 69.
    Izumi-Hisha H, Ito Y, Sugkmoto K, et al. Age-related decrease in the number of hemopoietic stem cells and progenitors in senescence accelerated mice. Mech Ageing Dev 1990; 56: 89–97PubMedGoogle Scholar
  70. 70.
    Szakal AK, Kapasi ZF, Masuda A, et al. Follicular dendritic cells in the alternative antigen transport pathway: microenvi-ronment, cellular events, age and retrovirus related alterations. Semin Immunol 1992; 4: 257–65PubMedGoogle Scholar
  71. 71.
    Beckman I, Dimopoulos K, Xaioning X, et al. T cell activation in the elderly: evidence for specific deficiencies in T cell/accessory cell interactions. Mech Ageing Dev 1990; 51: 265–76PubMedGoogle Scholar
  72. 72.
    McLachlan JA, Serkin CD, Morrey KM, et al. Antitumoral properties of aged human monocytes. J Immunol 1995; 154: 832–43PubMedGoogle Scholar
  73. 73.
    Itoh H, Abo T, Sugawara S, et al. Age-related variation in the proportion and activity of murine liver natural killer cells and their cytotoxicity against regenerating hepatocytes. J Immunol 1988; 141: 315–23PubMedGoogle Scholar
  74. 74.
    Ho S-P, Kramer KE, Ershler WB. Effect of host age upon interleukin-2-mediated anti-tumor responses in a murine fibrosarcoma model. Cancer Immunol Immunother 1990; 31: 146–50PubMedGoogle Scholar
  75. 75.
    Kutza J, Kaye D, Murasko DM. Basal natural killer cell activity of young versus elderly humans. J Gerontol 1991; 50A: B110–6Google Scholar
  76. 76.
    Kutza J, Murasko DM. Effects of aging on natural killer cell activity and activation by interleukin-2 and IFN-alpha. Cell Immunol 1994; 155: 195–204PubMedGoogle Scholar
  77. 77.
    Kutza J, Kaye D, Murasko DM. Basal natural killer cell activity of young versus elderly humans. J Gerontol 1995; 50A: B110–6Google Scholar
  78. 78.
    Esposito D, Fassina G, Szabo P, et al. Chromosomes of older humans are more prone to aminopterin-induced breakage. Proc Natl Acad Sci U S A 1989; 86: 1302–6PubMedGoogle Scholar
  79. 79.
    Akiyama M, Shou O-L, Kusunoki Y, et al. Age and dose related alteration of in vitro mixed lymphocyte culture response of blood lymphocytes from A-bomb survivors. Radiat Res 1989; 117: 26–34PubMedGoogle Scholar
  80. 80.
    Mayer PJ, Lange CS, Bradley MO, et al. Age-dependent decline in rejoining of X-ray-induced DNA double-strand breaks in normal human lymphocytes. Mutat Res 1989; 219: 95–100PubMedGoogle Scholar
  81. 81.
    Melaragno MI, Smith MdeA. Sister chromatid exchange and proliferation pattern in lymphocytes from newborns, elderly subjects and in premature aging syndromes. Mech Ageing Dev 1990; 54: 43–53PubMedGoogle Scholar
  82. 82.
    Goodwin JS, Webb DR. Regulation of the immune response by prostaglandins: a critical review. Clin Immunol Immunopathol 1981; 15: 116–32Google Scholar
  83. 83.
    Goodwin JS. Changes in lymphocyte sensitivity to prostaglandin E, histamine, hydrocortisone, and X-irradiation with age: studies in a healthy elderly population. Clin Immunol Immunopathol 1982; 25: 243–51PubMedGoogle Scholar
  84. 84.
    Hayek MG, Meydani S, Meydani M, et al. Age differences in eicosanoid production of mouse splenocytes; effects on mitogen-induced T cell proliferation. J Gerontol 1994; 49: B197–207PubMedGoogle Scholar
  85. 85.
    Benharka AA, Wu D, Han SN, et al. Macrophage prostaglandin production contributes to the age-associated decrease in T cell function which is reversed by the dietary antioxidant vitamin E. Mech Ageing Devel 1997; 93: 59–77Google Scholar
  86. 86.
    Riancho JA, Zarrabeitia MT, Amado JA, et al. Age-related differences in cytokine secretion. Gerontology 1994; 40: 8–12PubMedGoogle Scholar
  87. 87.
    Yoshikawa T, Suzuki H, Sugiyama E, et al. Effects of prostaglandin El on the production of IgM and IgG class antidsDNA antibodies in NZB/W Fl mice. J Rheum 1993; 20: 1701–6PubMedGoogle Scholar
  88. 88.
    Negoro S, Hara H, Miyata S, et al. Mechanisms of age-related decline in antigen-specific T cell proliferative response: IL-2 receptor expression and recombinant IL-2 induced proliferalive response of purified Tac-positive T cells. Mech Ageing Dev 1986; 36: 223–41PubMedGoogle Scholar
  89. 89.
    McElhaney JE, Beatde BL, Devine R, et al. Age-related decline in interleukin 2 production in response to influenza vaccine. J Am Geriatr Soc 1990; 38: 652–8PubMedGoogle Scholar
  90. 90.
    Vissinga C, Hertogh-Huijbregts A, Rozing J, et al. Analysis of the age-related decline in alloreacdvity of CD4+ and CD8+ T cells in CBA/RIJ mice. Mech Ageing Dev 1990; 51: 179–94PubMedGoogle Scholar
  91. 91.
    Hara H, Tanaka T, Negoro S, et al. Age-related changes of expression of IL-2 receptor subunits and kinetics of IL-2 internalization in T cells after mitogenic stimulation. Mech Ageing Dev 1988; 45: 167–75PubMedGoogle Scholar
  92. 92.
    Nagel JE, Chopra RK, Powers DC, et al. Effect of age on the human high affinity interleukin 2 receptor of phytohaemagglutinin sdmulated peripheral blood lymphocytes. Clin Exp Immunol 1989; 75: 286–91PubMedGoogle Scholar
  93. 93.
    Goonewardene IM, Murasko DM. Age associated changes in mitogen induced proliferation and cytokine production by lymphocytes of the long-lived brown Norway rat. Mech Ageing Dev 1993; 71: 199–212PubMedGoogle Scholar
  94. 94.
    Ajitsu S, Mirabella S, Kawanishi H. In vivo immunologic intervention in age-related T cell defects in murine gut-associated lymphoid tissues by IL-2. Mech Ageing Dev 1990; 54: 163–83PubMedGoogle Scholar
  95. 95.
    Hobbs MV, Ernst DN, Torbett BE, et al. Cell proliferation and cytokine production by CD4+ cells from old mice. J Cell Biochem 1991; 46: 312–20PubMedGoogle Scholar
  96. 96.
    Wu W, Pahlavani M, Cheung HT, et al. The effect of aging on the expression of interleukin 2 messenger ribonucleic acid. Cell Immunol 1986; 100: 224–31PubMedGoogle Scholar
  97. 97.
    Bradley SF, Vibhagool A, Kunkel SL, et al. Monokine secretion in aging and protein malnutrition. J Leukoc Biol 1989; 45: 510–4PubMedGoogle Scholar
  98. 98.
    Molteni M, Delia Bella S, Mascagni B, et al. Secretion of cytokines upon allogeneic stimulation: effect of aging. J Biol Regul Homeost Agents 1994; 8: 41–7PubMedGoogle Scholar
  99. 99.
    Udhayakumar V, Subbarao B, Seth A, et al. Impaired T cell-induced T cell-T cell interaction in aged mice. Cell Immunol 1988; 116: 299–307PubMedGoogle Scholar
  100. 100.
    Thoman ML, Keogh EA, Weigle WO. Response of aged T and B cells to interleukin-4. Aging Immunol Infect Dis 1988/1989; 1: 245–53Google Scholar
  101. 101.
    Li SP, Miller RA. Age-associated decline in IL-4 production by murine T lymphocytes in extended culture. Cell Immunol 1993; 151: 187–95PubMedGoogle Scholar
  102. 102.
    Dobber R, Tielemans M, Nagelkerken L. The in vivo effects of neutralizing antibodies against IFN-gamma, IL-4, or IL-10 on the humoral immune response in young and aged mice. Cell Immunol 1995; 160: 185–92PubMedGoogle Scholar
  103. 103.
    Burns EA, I’Hommedieu GD, Cunning J, et al. Effects of interleukin 4 on andgen-specific andbody synthesis by lymphocytes from old and young adults. Lymphokine Cytokine Res 1994; 13(4): 227–31PubMedGoogle Scholar
  104. 104.
    Candore G, Di Lorenzo G, Melluso M, et al. Gamma-interferon, interleukin-4 and interleukin-6 in vitro production in old subjects. Autoimmunity 1993; 16: 275–80PubMedGoogle Scholar
  105. 105.
    Nagelkerken L, Hertogh-Huijbregts A, Dobber R, et al. Age-related changes in lymphokine production related to a decreased number of CD45RBhi CD4+ T cells. Eur J Immunol 1991; 21: 273–81PubMedGoogle Scholar
  106. 106.
    Kutza J, Jurasko DM. Effects of aging on natural killer cell activity and activation by interleukin-2 and IFN-alpha. Cell Immunol 1994; 155: 195–204PubMedGoogle Scholar
  107. 107.
    Krishnaraj R, Bhooma T. Cytokine sensidvity of human NK cells during immunosenescence: 2. IL-2-induced interferon gamma secretion. Immunol Lett 1996; 50: 59–63PubMedGoogle Scholar
  108. 108.
    Caruso C, Candore G, Cigna D, et al. Cytokine production pathway in the elderly. Immunol Res 1996; 15: 84–90PubMedGoogle Scholar
  109. 109.
    Faist E, Markewitz A, Fuchs D, et al. Immunomodulatory therapy with thymopendn and indomethacin: successful restoration of interleukin-2 synthesis in patients undergoing major surgery. Ann Surg 1991; 214: 264–73PubMedGoogle Scholar
  110. 110.
    Chopra RK, Holbrook NJ, Powers DC, et al. Interleukin 2, interleukin 2 receptor, and interferon-gamma synthesis and mRNA expression in phorbol myristate acetate and calcium ionophore A23187-sdmulated T cells from elderly humans. Clin Immunol Immunopathol 1989; 53: 297–308PubMedGoogle Scholar
  111. 111.
    Daynes RA, Araneo BA, Ershler WB, et al. Altered regulation of IL-6 production with normal aging. J Immunol 1993; 150: 5219–30PubMedGoogle Scholar
  112. 112.
    Ershler WB. Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc 1993; 41: 176–81PubMedGoogle Scholar
  113. 113.
    Sothern RB, Roitman-Johnson B, Kanabrocki EL, et al. Circadian characterisdcs of circulating interleukin-6 in men. J Allergy Clin Immunol 1995; 95: 1029–35PubMedGoogle Scholar
  114. 114.
    Liao Z, Caucino JA, Schniffer SM, et al. Increased urinary cytokine levels in the elderly. Aging Immunol Infect Dis 1993; 4: 139–53Google Scholar
  115. 115.
    Foster KD, Conn CA, Kluger MJ. Fever, tumor necrosis factor and interleukin-6 in young, mature and aged Fischer 344 rats. Am J Physiol 1992; 262: R211–5PubMedGoogle Scholar
  116. 116.
    Clark JA, Peterson TC. Cytokine production and aging: overproduction of IL-8 in elderly males in response to lipopoly-saccharide. Mech Ageing Dev 1994; 77: 127–39PubMedGoogle Scholar
  117. 117.
    Goodwin JS. Decreased immunity and increased morbidity in the elderly. Nutr Rev 1995; 53: S41–6PubMedGoogle Scholar
  118. 118.
    Bender BS, Nagel JE, Adler WH, et al. Absolute peripheral blood lymphocyte counts and subsequent mortality of elderly men. J Am Geriatr Soc 1986; 34: 649–54PubMedGoogle Scholar
  119. 119.
    Ferguson EG, Wikby A, Maxson P, et al. Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors. J Gerontol 1995; 50: B378–82Google Scholar
  120. 120.
    Wayne S, Rhyne R, Garry P, et al. Cell mediated immunity as a predictor of morbidity and mortality in the aged. J Gerontol 1990; 45: 45–9Google Scholar
  121. 121.
    Belch JJ. The relationship between white blood cells and arterial disease. Curr Opin Lipidol 1994; 5: 440–6PubMedGoogle Scholar
  122. 122.
    Clarkson RB, Alexander NJ. Long term vasectomy: effects on the occurrence and extent of atherosclerosis in rhesus monkeys. J Clin Invest 1980; 65: 15–25PubMedGoogle Scholar
  123. 123.
    Ansbacher R, Keung-Yeung K, Wurster JC. Sperm andbodies in vasectomized men. Fertil Steril 1972; 23: 640–3PubMedGoogle Scholar
  124. 124.
    Minick CR, Murphy GE, Campbell WG. Experimental induction of athero-arteriosclerosis by the synergy of allergic injury to arteries and lipid rich diet. J Exp Med 1966; 124: 635–52PubMedGoogle Scholar
  125. 125.
    Howard AN, Paterski J, Bowyer DE, et al. Atherosclerosis induced in hypercholesterolemic baboons by immunologic injury. Atherosclerosis 1971; 14: 17–29PubMedGoogle Scholar
  126. 126.
    Geng YJ, Holm J, Nygren S, et al. Expression of the macrophage scavenger receptor in atheroma: relationship to immune acdvation and the T-cell cytokine interferon-gamma. Arterioscler Thromb Vasc Biol 1995; 15: 1995–2002PubMedGoogle Scholar
  127. 127.
    Shimokama T, Haraoka S, Watanabe T. Morphological fate and sequelae of human atherosclerosis: evaluation of immune mechanisms in atherogenesis through immunohistological and ultrastructural analysis. Pathol Int 1995; 45: 801–14PubMedGoogle Scholar
  128. 128.
    Mackay IR, Whittingham SE, Mathews JD. The immunoepidemiology of aging. In: Makinodan T, Yunis E, editors. Immunology and aging. New York: Plenum Press, 1977: 35–50Google Scholar
  129. 129.
    Beeson PB. Age and sex associations of 40 autoimmune diseases. Am J Med 1994; 96: 457–62PubMedGoogle Scholar
  130. 130.
    Salvarani C, Gabriel SE, O’Fallon WM, et al. The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med 1995; 123: 192–4PubMedGoogle Scholar
  131. 131.
    Goodwin JS. Progress in gerontology: polymyalgia rheumatica and temporal arteritis. J Am Geriatr Soc 1992; 40: 515–25PubMedGoogle Scholar
  132. 132.
    Baldursson O, Steinsson K, Bjornsson J, et al. Giant cell arteritis in Iceland: an epidemiologic and histopathologic analysis. Arthritis Rheum 1994; 37: 1007–12PubMedGoogle Scholar
  133. 133.
    Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med 1996; 156: 1097–100PubMedGoogle Scholar
  134. 134.
    Stratta P, Segoloni GP, Canavese C, et al. Incidence of biopsy-proven primary glomerulonephritis in an Italian province. Am J Kidney Dis 1996; 27: 631–9PubMedGoogle Scholar
  135. 135.
    Simon P, Ramee MP, Autuly V, et al. Epidemiology of primary glomerular diseases in a French region: variations according to period and age. Kidney Int 1994; 46: 1192–8PubMedGoogle Scholar
  136. 136.
    Schon F, Drayson M, Tompson RA. Myasthenia gravis and elderly people. Age Ageing 1996; 25: 56–8PubMedGoogle Scholar
  137. 137.
    Wallace WA, Schofield JA, Lamb D, et al. Localisation of a pulmonary autoantigen in cryptogenic fibrosing alveolitis. Thorax 1994; 49: 1139–45PubMedGoogle Scholar
  138. 138.
    Wallace WA, Roberts SN, Caldwell H, et al. Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis. Thorax 1994; 49: 218–22PubMedGoogle Scholar
  139. 139.
    Prior C, Haslam PL. In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases. Clin Exp Immunol 1992; 88: 280–7PubMedGoogle Scholar
  140. 140.
    Ma JY, Borch K, Mardh S. Human gastric H,K-adenosine triphosphatase beta-subunit is a major autoantigen in atrophic corpus gastritis: expression of the recombinant human glycoprotein in insect cells. Scand J Gastroenterol 1994; 29: 790–4PubMedGoogle Scholar
  141. 141.
    Martinez-Taboada VM, Goronzy JJ, Weyand CM. Clonally expanded CD8 T cells in patients with polymyalgia rheumatica and giant cell arteritis. Clin Immunol Immunopathol 1996; 79: 263–70PubMedGoogle Scholar
  142. 142.
    Macchioni P, Boiardi L, Salvarani C, et al. Lymphocyte sub-populations analysis in peripheral blood in polymyalgia rheumatica/giant cell arteritis. Br J Rheum 1993; 32: 666–70Google Scholar
  143. 143.
    Yi Q, He W, Matell G, et al. T and B lymphocytes reacting with the extracellular loop of the beta 2-adrenergic receptor (beta 2AR) are present in the peripheral blood of patients with myasthenia gravis. Clin Exp Immunol 1996; 103: 133–40PubMedGoogle Scholar
  144. 144.
    Ofosu-Appiah W, Mokhtarian F, Shirazian D, et al. Production of anti-acetylcholine receptor-alpha antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: role of immunoregulatory T cells and monocytes. J Lab Clin Med 1994; 124: 231–41PubMedGoogle Scholar
  145. 145.
    Egan JJ, Stewart JP, Hasleton PS, et al. Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. Thorax 1995; 50: 1234–9PubMedGoogle Scholar
  146. 146.
    Ma JY, Borch K, Sjostrand SE, et al. Positive correlation between H,K-adenosine triphosphatase autoantibodies and Helicobacter pylori antibodies in patients with pernicious anemia. Scand J Gastroenterol 1994; 29: 961–5PubMedGoogle Scholar
  147. 147.
    Burns EA, Goodwin JS. Immunology and infectious disease. In: Cassel CK, Riesenberg DE, Sorensen LB, editors. Geriatric medicine. 2nd ed. New York: Springer-Verlag, 1990: 312–29Google Scholar
  148. 148.
    Sullivan KM, Monto AS, Longini Jr IM. Estimates of the US health impact of influenza. Am J Public Health 1993; 83: 1712–6PubMedGoogle Scholar
  149. 149.
    Fagiolo U, Amadori A, Cozzi E, et al. Humoral and cellular immune response to influenza virus vaccination in aged humans. Aging 1993; 5: 451–8PubMedGoogle Scholar
  150. 150.
    Ben-Yehuda A, Ehleiter D, Hu AR, et al. Recombinant vaccinia virus expressing the PR/8 influenza hemagglutinin gene overcomes the impaired immune response and increased susceptibility of old mice to influenza infection. J Infect Dis 1993; 168: 352–7PubMedGoogle Scholar
  151. 151.
    Kutza J, Gross P, Kaye D, et al. Natural killer cell cytotoxicity in elderly humans after influenza immunization. Clin Diagn Lab Immunol 1996; 3: 105–8PubMedGoogle Scholar
  152. 152.
    Swenson CD, Cherniack EP, Russo C, et al. IgD-receptor up-regulation on human peripheral blood T cells in response to IgD in vitro or antigen in vivo correlates with the antibody response to influenza vaccination. Eur J Immunol 1996; 26: 340–4PubMedGoogle Scholar
  153. 153.
    Remarque EJ, van Beek WC, Ligthart GJ, et al. Improvement of the immunoglobulin subclass response to influenza vaccine in elderly nursing home residents by the use of high-dose vaccines. Vaccine 1993; 11: 649–54PubMedGoogle Scholar
  154. 154.
    Gross PA, Quinnan GV, Rodstein M, et al. Association of influenza immunization with reduction in mortality in an elderly population. Arch Intern Med 1988; 148: 562–5PubMedGoogle Scholar
  155. 155.
    Arden NH, Patriarca PA, Kendal AP. Experiences in the use and efficacy of inactivated influenza vaccine in nursing homes. In: Kendal AP, Patriarca PA, editors. Options for the control of influenza. New York: Alan R. Liss Inc., 1986: 155–68Google Scholar
  156. 156.
    Advisory Committee on Immunization Practices. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 1997; 46S: 1–20Google Scholar
  157. 157.
    Dunlap NE, Ballinger S, Reed T, et al. The use of monozygotic and dizygotic twins to estimate the effects of inheritance on the levels of immunoglobulin isotypes and antibodies to phosphocholine. Clin Immunol Immunopathol 1993; 66: 176–80PubMedGoogle Scholar
  158. 158.
    Nicoletti C. Antibody protection in aging: influence of idiotypic repertoire and antibody binding activity to a bacterial antigen. Exp Mol Pathol 1995; 62: 99–108PubMedGoogle Scholar
  159. 159.
    Borghesi C, Nicoletti C. Increase of cross(auto)-reactive antibodies after immunization in aged mice: a cellular and molecular study. Int J Exp Pathol 1994; 75: 123–30PubMedGoogle Scholar
  160. 160.
    Stein BE. Adult vaccinations: protecting your patients from avoidable illness. Geriatrics 1993; 48: 46, 49-52, 55PubMedGoogle Scholar
  161. 161.
    Sims RV, Steinmann WC, McConville JH, et al. The clinical effectiveness of pneumococcal vaccine in the elderly. Ann Intern Med 1988; 108: 653–7PubMedGoogle Scholar
  162. 162.
    Sharma N, Trubuhovich R, Thomas MG. Tetanus in Auckland: a preventable disease. N Z Med J 1994; 107: 82–4PubMedGoogle Scholar
  163. 163.
    Zuber PL, Schierz A, Arestegui G, et al. Tetanus in Switzerland 1980–1989. Eur J Epidemiol 1993; 9: 617–24PubMedGoogle Scholar
  164. 164.
    Gergen PJ, McQuillan TM, Kiely M, et al. A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med 1995; 332: 761–6PubMedGoogle Scholar
  165. 165.
    Knight AL, Richardson JP. Management of tetanus in the elderly. J Am Board Fam Pract 1992; 5: 43–9PubMedGoogle Scholar
  166. 166.
    Prevots R, Sutter RW, Strebel PM, et al. Tetanus surveillance -United States, 1989–1990. MMWR CDC Surveill Summ 1992; 41: 1–9PubMedGoogle Scholar
  167. 167.
    Ballestra DJ, Littenberg B. Should adult tetanus immunization be given as a single vaccination at age 65? A cost-effectiveness analysis. J Gen Intern Med 1003; 8: 405–12Google Scholar
  168. 168.
    Lichtenhan JB, Kellerman RD, Richards JF. Tetanus: a threat to elderly patients. Postgrad Med 1992; 92: 59–60, 65–7, 70–2PubMedGoogle Scholar
  169. 169.
    Stead WW, Lofgren JP, Warren E, et al. Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes. N Engl J Med 1985; 312: 1483–7PubMedGoogle Scholar
  170. 170.
    Stead WW, To T. The significance of the tuberculin skin test in elderly persons. Ann Intern Med 1987; 107: 837–42PubMedGoogle Scholar
  171. 171.
    Cooper AM, Callahan JE, Griffin JP, et al. Old mice are able to control low-dose aerogenic infections with Mycobacterium tuberculosis. Infect Immunol 1995; 63: 3259–65Google Scholar
  172. 172.
    Orme IM, Griffin JP, Roberts AD, et al. Evidence for a defective accumulation of protective T cells in old mice infected with Mycobacterium tuberculosis. Cell Immunol 1993; 147: 222–9PubMedGoogle Scholar
  173. 173.
    Orme IM. Mechanisms underlying the increased susceptibility of aged mice to tuberculosis. Nutr Rev 1995; 53: S35–40PubMedGoogle Scholar
  174. 174.
    Orme IM. Aging and immunity to tuberculosis: increased susceptibility of old mice reflects a decreased capacity to generate mediator T lymphocytes. J Immunol 1988; 140: 3589–93PubMedGoogle Scholar
  175. 175.
    Orme IM. The response of macrophages from old mice to Mycobacterium tuberculosis and its products. Aging Immunol Infect Dis 1993; 4: 187–95Google Scholar
  176. 176.
    Ragozzino MW, Melton III LJ, Kurland LT, et al. Population-based study of herpes zoster and its sequelae. Medicine 1982; 61: 310–6PubMedGoogle Scholar
  177. 177.
    Donahue JG, Choo PW, Manson JE, et al. The incidence of herpes zoster. Arch Intern Med 1995; 155: 1605–9PubMedGoogle Scholar
  178. 178.
    Burke BL, Steele RW, Beard OW, et al. Immune responses to varicella-zoster in the aged. Arch Intern Med 1982; 142: 291–3PubMedGoogle Scholar
  179. 179.
    Ragozzino MW, Melton III LJ, Kurland LT, et al. Risk of cancer after herpes zoster: a population-based study. N Engl J Med 1982; 307: 393–7PubMedGoogle Scholar
  180. 180.
    Lee JJ, Gauci CA. Postherpedc neuralgia: current concepts and management. Br J Hosp Med 1994/1995; 52: 565–7PubMedGoogle Scholar
  181. 181.
    Whidey RJ. Therapeudc approaches to varicella-zoster virus infections. J Infect Dis 1992; 166 Suppl. 1: S51–7Google Scholar
  182. 182.
    Kainer M, Mills J. Treatment of herpes simplex and varicella zoster infections. Aust Fam Physician 1994; 23: 2157–61, 2164-6PubMedGoogle Scholar
  183. 183.
    Beutner KR, Friedman DJ, Forszpaniak C, et al. Valacyclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Andmicrob Agents Chemother 1995; 39: 1546–53Google Scholar
  184. 184.
    Takahashi M. Current status and prospects of live varicella vaccine. Vaccine 1992; 10: 1007–14PubMedGoogle Scholar
  185. 185.
    Davies J, Hallworth JA, McLeish P, et al. Characterization and immunogenicity of a candidate subunit vaccine against varicella-zoster virus. Med Microbiol Immunol 1994; 183: 105–17PubMedGoogle Scholar
  186. 186.
    Gallo RC, Wong-Staal F. A human T-lymphotrophic retrovirus (HTLV-III) as the cause of AIDS. Ann Intern Med 1985; 103: 679–89PubMedGoogle Scholar
  187. 187.
    First 500,000 AIDS cases — United States, 1995. MMWR Morb Mortal Wkly Rep 1995; 44: 849–53Google Scholar
  188. 188.
    Adler WH, Nagel JE. Acquired immunodeficiency syndrome in the elderly. Drugs Aging 1994; 4: 410–6PubMedGoogle Scholar
  189. 189.
    Stall R, Catania J. AIDS risk behaviors among late middle-aged and elderly Americans. Arch Intern Med 1994; 154: 57–63PubMedGoogle Scholar
  190. 190.
    Steel M. IVth international AIDS conference. Lancet 1988; II: 54–5Google Scholar
  191. 191.
    Darby SC, Ewart DW, Giangrande PL, et al. Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. Lancet 1996; 347: 1573–9PubMedGoogle Scholar
  192. 192.
    Burnet FM. The concept of immunological surveillance. Prog Exp Tumor Res 1970; 13: 1–27PubMedGoogle Scholar
  193. 193.
    Thomas L. Reactions to homologous tissue antigens in relation to hypersensitvity. In: Lawrence HS, editor. Cellular and humoral aspects of the hypersensitivity states. New York: Hoeber-Harper, 1959: 529–32Google Scholar
  194. 194.
    Gatd RA, Good RA. Aging, immunity and malignancy. Geriatrics 1970; 25: 158–68Google Scholar
  195. 195.
    Fraumeni JF, Hoover RN, Devesa SS, et al. Epidemiology of cancer. In: DeVita Jr VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 4th ed. Philadelphia: Lippincott, 1993: 150–81Google Scholar
  196. 196.
    Newell GR, Spitz MR, Sider JG. Cancer and age. Semin Oncol 1989; 16: 3–9PubMedGoogle Scholar
  197. 197.
    Vogelstein B, Fearon ER, Hamilton SR, et al. Genedc alterations during colorectal tumor development. N Engl J Med 1988; 319: 525–32PubMedGoogle Scholar
  198. 198.
    Pike MC. Age-related factors in cancer of the breast, ovary and endometrium. J Chronic Dis 1987; 40 Suppl. 2: S59–69Google Scholar
  199. 199.
    Cantor KP, Fraumeni JF. Distribution of non-Hodgkin’s lymphoma in the United States between 1950 and 1975. Cancer Res 1980; 40: 2645–50PubMedGoogle Scholar
  200. 200.
    Ershler WB. The influence of an aging immune system on cancer incidence and progression. J Gerontol 1993; 48: B3–7PubMedGoogle Scholar
  201. 201.
    Ader R, Cohen N. Conditioned immunopharmacologic responses. In: Ader R, editor. Psychoneuroimmunology. Orlando (FL): Academic Press Inc., 1981: 281–317Google Scholar
  202. 202.
    Borysenko M, Borysenko J. Stress, behavior and immunity: animal models and mediating mechanisms. Gen Hosp Psychiatry 1982; 4: 59–67PubMedGoogle Scholar
  203. 203.
    Rosenberg LT, Coe CL, Levine S. Complement levels in the squirrel monkey. Lab Anim Sci 1982; 32: 371–2PubMedGoogle Scholar
  204. 204.
    Minter RE, Patterson-Kimball C. Life events and illness onset: a review. Psychosomatics 1978; 19: 334–9PubMedGoogle Scholar
  205. 205.
    Glaser R, Thorn BE, Tarr KL, et al. Effects of stress on methyltransferase synthesis: an important DNA repair enzyme. Health Psychol 1985; 4: 403–12PubMedGoogle Scholar
  206. 206.
    Thomas PD, Goodwin JM, Goodwin JS. Effect of social support on stress-related changes in cholesterol level, uric acid level and immune function in an elderly sample. Am J Psychiatry 1985; 142: 735–7PubMedGoogle Scholar
  207. 207.
    Bartoloni C, Guidi L, Andco L, et al. Psychological status and immunological parameters of institutionalized aged. Panminerva Med 1991; 33: 164–9PubMedGoogle Scholar
  208. 208.
    Glaser R, Kiecolt-Glaser JK, Speicher CE, et al. The relationship of stress and loneliness and changes in herpes virus latency. J Behav Med 1985; 8: 249–60PubMedGoogle Scholar
  209. 209.
    Glaser R, Pearson GR, Bonneau RH, et al. Stress and the memory T cell response to the Epstein-Barr virus in healthy medical students. Health Psychol 1993; 12: 435–42PubMedGoogle Scholar
  210. 210.
    Kielcolt-Glaser JK, Glaser R, Gravenstein S, et al. Chronic stress alters the immune response to influenza virus vaccine in older adults. Proc Natl Acad Sci U S A 1996; 93: 3043–7Google Scholar
  211. 211.
    Kiecolt-Glaser JK, Marucha PT, Malarkey WH, et al. Slowing of wound healing by psychological stress. Lancet 1995; 346: 1194–6PubMedGoogle Scholar
  212. 212.
    Fabris N. A neuroendocrine-immune theory of aging. Int J Neurosci 1990; 51: 373–5PubMedGoogle Scholar
  213. 213.
    Song L, Kim YH, Chopra RK, et al. Age-related effects in T cell activation and proliferation. Exp Gerontol 1993; 28: 313–21PubMedGoogle Scholar
  214. 214.
    Lewis V, Twomey J, Bealmear P, et al. Age, thymic function and circulating thymic hormone activity. J Clin Endocrinol Metab 1978; 47: 145–52PubMedGoogle Scholar
  215. 215.
    Hirokawa K, Utsuyama M, Kasai M, et al. Aging and immunity. Acta Pathol Jpn 1992; 42: 537–48PubMedGoogle Scholar
  216. 216.
    Effros RB, Casillas A, Walford RL. The effect of thymosin-1 immunity to influenza in aged mice. Aging Immunol Infect Dis 1988; 1: 31–40Google Scholar
  217. 217.
    Goso C, Frasca D, Doria G. Effect of synthetic thymic humoral factor (THF-gamma 2) on T cell activities in immunodeficient ageing mice. Clin Exp Immunol 1992; 87: 346–51PubMedGoogle Scholar
  218. 218.
    Frasca D, Adorini L, Doria G. Enhanced frequency of mitogen-responsive T cell precursors in old mice injected with thymosin alpha 1. Eur J Immunol 1987; 17: 727–30PubMedGoogle Scholar
  219. 219.
    Cillari E, Milano S, Perego R, et al. Modulation of IL-2, IFN-gamma, TNF-alpha and IL-4 production in mice of different ages by thymopentin. Int J Immunopharmacol 1991; 14: 1029–35Google Scholar
  220. 220.
    Duchateau J, Servais G, Vreyens R, et al. Modulation of immune response in aged humans through different administration modes of thymopentin. Surv Immunol Res 1985; 4 Suppl. 1: 94–101PubMedGoogle Scholar
  221. 221.
    Ershler WB, Moore AL, Hacker MP, et al. Specific antibody synthesis in vitro: II. Age-associated thymosin enhancement of anti-tetanus antibody synthesis. Immunopharmacology 1984; 8: 69–77PubMedGoogle Scholar
  222. 222.
    Meroni PL, Barcellini W, Frasca D, et al. In vivo immunopotentiating activity of thymopentin in aging humans: increase of IL-2 production. Clin Immunol Immunopathol 1987; 42: 151–9PubMedGoogle Scholar
  223. 223.
    Cillari E, Milano S, Dieli M, et al. Thymopentin reduces the susceptibility of aged mice to cutaneous leishmaniasis by modulating CD4 T-cell subsets. Immunology 1992; 76: 362–6PubMedGoogle Scholar
  224. 224.
    Reiter RJ. Pineal function during aging: attenuation of the melatonin rhythm and its neurobiological consequences. Acta Neurobiol Exp (Warsz) 1994; 54: S31–9Google Scholar
  225. 225.
    Lissoni P, Brivio O, Fumagalli L, et al. Immune effects of preoperative immunotherapy with high-dose subcutaneous interleukin-2 versus neuroimmunotherapy with low-dose IL-2 plus the neurohormone melatonin in gastrointestinal tract tumor patients. J Biol Regul Homeost Agents 1995; 9: 31–3PubMedGoogle Scholar
  226. 226.
    Lissoni P, Barni S, Fossati V, et al. A randomized study of neuroimmunotherapy with low-dose subcutaneous interleukin-2 plus melatonin compared to supportive care alone in patients with untreatable metastatic solid tumour. Support Care Cancer 1995; 3: 194–7PubMedGoogle Scholar
  227. 227.
    Caroleo MC, Frasca D, Nistico G, et al. Melatonin: an immunomodulator in immunodeficient mice. Immunopharmacology 1992; 23: 81–9PubMedGoogle Scholar
  228. 228.
    Saito H, Inoue T, Fukatsu K, et al. Growth hormone and the immune response to bacterial infection. Hormone Res 1996; 45: 50–4PubMedGoogle Scholar
  229. 229.
    Auernhammer CJ, Feldmeier H, Nass R, et al. Insulin-like growth factor I is an independent coregulatory modulator of NK cell activity. Endocrinology 1996; 137: 5332–6PubMedGoogle Scholar
  230. 230.
    Bonello RS, Marcus R, Bloch D, et al. Effects of growth hormone and estrogen on T lymphocytes in older women. J Am Geriatr Soc 1996; 44: 1039–42Google Scholar
  231. 231.
    Swenson CD, Gottesman SR, Belsito DV, et al. Relationship between humoral immunoaugmenting properties of DHEAS and IgD-receptor expression in young and aged mice. Ann N Y Acad Sci 1995; 29: 249–58Google Scholar
  232. 232.
    Araneo BA, Woods II ML, Daynes RA. Reversal of the immunosenescent phenotype by DHEA: hormone treatment provides an adjuvant effect on the immunization of aged mice with recombinant hepatitis B surface antigen. J Infect Dis 1993; 167: 830–40PubMedGoogle Scholar
  233. 233.
    Danenberg HD, Ben-Yehuda A, Zakay-Rones Z, et al. DHEA treatment reverses the impaired immune response of old mice to influenza vaccination and protects from influenza infection. Vaccine 1995; 13: 1445–8PubMedGoogle Scholar
  234. 234.
    Araneo B, Dowell T, Woods ML, et al. DHEAS as an effective vaccine adjuvant in elderly humans: proof-of-principle studies. Ann N Y Acad Sci 1995; 774: 232–48PubMedGoogle Scholar
  235. 235.
    Chandra RK. Nutrition is an important determinant of immunity in old age. Prog Clin Biol Res 1990; 326: 321–34PubMedGoogle Scholar
  236. 236.
    Burns EA, Goodwin JS. Aging: nutrition and immunity. In: Forse RA, Bell SJ, Blackburn GL, editors. Diet, nutrition and immunity. Boca Raton (FL): CRC Press, 1994: 57–72Google Scholar
  237. 237.
    Effros RB, Walford RL, Weindruch R, et al. Influences of dietary restriction on immunity to influenza in aged mice. J Gerontol 1991; 46: B142–7PubMedGoogle Scholar
  238. 238.
    Ershler WB, Sun WH, Binkley N, et al. Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lymphokine Cytokine Res 1993; 12: 225–30PubMedGoogle Scholar
  239. 239.
    Kemintz JW, Weindruch R, Roecker EB, et al. Dietary restriction of adult male rhesus monkeys: design, methodology, and preliminary findings from the first year of study. J Gerontol 1993; 48: B17–26Google Scholar
  240. 240.
    Chandra RK, Puri S. Nutritional support improves antibody response to influenza vaccine in the elderly. BMJ 1985; 291: 705–6PubMedGoogle Scholar
  241. 241.
    Chandra RK. Effect of vitamin and trace-element supplementation on immune responses and infection in elderly subjects. Lancet 1992; 340: 1124–7PubMedGoogle Scholar
  242. 242.
    Rasmussen LB, Kiens B, Pedersen BK, et al. Effect of diet and plasma fatty acid composition on immune status in elderly men. Am J Clin Nutr 1994; 59: 572–7PubMedGoogle Scholar
  243. 243.
    Meydani M. Vitamin E. Lancet 1995; 345: 170–5PubMedGoogle Scholar
  244. 244.
    Meydani SN, Hayek M. Vitamin E and immune response. In: Chandra RK, editor. Nutrition and immunology. St John’s (Newfoundland): ARTS Biomedical Publishers and Distributors, 1992: 105–28Google Scholar
  245. 245.
    Wu D, Meydani SN, Sastre J, et al. In vitro glutathione supplementation enhances interleukin-2 production and mitogenic response of peripheral blood mononuclear cells from young and old subjects. J Nutr 1994; 124: 655–63PubMedGoogle Scholar
  246. 246.
    Meydani SN, Barklund PM, Liu S, et al. Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects. Am J Clin Nutr 1990; 52: 557–63PubMedGoogle Scholar
  247. 247.
    Meydani SN, Meydani M, Blumberg JB, et al. Vitamin E supplementation and in vivo immune response in healthy elderly subjects: a randomised controlled trial. JAMA 1997; 277: 1380–6PubMedGoogle Scholar
  248. 248.
    Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 1996; 88: 1550–9PubMedGoogle Scholar
  249. 249.
    Albanes D, Heinonen OP, Taylor PR, et al. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996; 88: 1560–70PubMedGoogle Scholar
  250. 250.
    Goodwin JS, Bankhurst A, Murphy S, et al. Partial reversal of the cellular immune defect in common variable immunodeficiency with indomethacin. J Clin Lab Immunol 1978; 1: 197–9PubMedGoogle Scholar
  251. 251.
    Hsia J, Tang T, Parrott M, et al. Augmentation of the immune response to influenza vaccine by acetylsalicylic acid: a clinical trial in a geriatric population. Methods Find Exp Clin Pharmacol 1994; 16: 677–83PubMedGoogle Scholar
  252. 252.
    Cueppens J, Rodriguez M, Goodwin JS. Nonsteroidal anti-inflammatory drugs inhibit the production of IgM rheumatoid factor in vitro. Lancet 1982; I: 528–31Google Scholar
  253. 253.
    Levin MJ, Murray M, Zerbe GO, et al. Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine. J Infect Dis 1994; 170: 522–6PubMedGoogle Scholar
  254. 254.
    Levine M, Beattie BL, McLean DM. Comparison of 1 and 2-dose regimens of influenza vaccine for elderly men. Can Med Assoc J 1987; 137: 722–6Google Scholar
  255. 255.
    Powers DC, Manning MC, Hanscome PJ, et al. Cytotoxic T lymphocyte responses to a liposome-adjuvanted influenza A virus vaccine in the elderly. J Infect Dis 1995; 172: 1103–7PubMedGoogle Scholar
  256. 256.
    Bleackley RC. Split-virus influenza vaccines: do they provide adequate immunity in the elderly? J Gerontol 1994; 49: M37–43PubMedGoogle Scholar
  257. 257.
    Gorse GJ, Campbell MJ, Otto EE, et al. Increased anti-influenza A virus cytotoxic T cell activity following vaccination of the chronically ill elderly with live attenuated or inactivated influenza virus vaccine. J Infect Dis 1995; 172: 1–10PubMedGoogle Scholar
  258. 258.
    Pennebaker JW, Kiecolt-Glaser JK, Glaser R. Disclosure of traumas and immune function: health implications for psychotherapy. J Consult Clin Psychol 1988; 56: 239–45PubMedGoogle Scholar
  259. 259.
    Kiecolt-Glaser JK, Glaser R, Williger D, et al. Psychosocial enhancement of immunocompetence in a geriatric population. Health Psychol 1985; 4: 25–41PubMedGoogle Scholar

Copyright information

© Adis International Limited 1997

Authors and Affiliations

  1. 1.Section of Geriatrics, Department of MedicineUniversity of Wisconsin Medical SchoolMilwaukeeUSA
  2. 2.Section of Geriatrics, Department of MedicineUniversity of Texas Medical BranchGalvestonUSA

Personalised recommendations